Article

Aesthesiometer offers different way to measure functional recovery

Claes Feinbaum, OD, of Alicante, Spain, outlined the results of an ongoing study comparing a new type of aesthesiometer with a unit that has been the standard for 45 years to determine the accuracy and efficiency if the newer aesthesiometer.

Paris—Claes Feinbaum, OD, of Alicante, Spain, outlined the results of an ongoing study comparing a new type of aesthesiometer with a unit that has been the standard for 45 years to determine the accuracy and efficiency if the newer aesthesiometer.

Aesthesiometry is used to measure the functional recovery following refractive surgery. Dr. Feinbaum presented his data at a free paper session on refractive surgery at the European Society of Cataract and Refractive Surgeons meeting.

Until recently, the Cochet-Bonnet aesthesiometer was used among surgeons to measure functional recovery. In the study, a new aesthesiometer, the Non-Contact Corneal Aesthesiometer (NCCA), is used. The differences are that the NCCA measures the C-fibers of the cornea, because of their physical approximation to the stimulus, while the Cochet-Bonnet unit measures the A-delta fibers.

Dr. Feinbaum explained how the NCCA stimulates the cornea by releasing a controlled pulse of air toward the corneal surface. An air-jet is positioned 1 cm away from the corneal surface and a stimulus air-pulse is aimed at the eye. The subjects respond verbally whether they feel the stimulus. Depending on their responses, the pressure of the pulse is modified, and/or a new stimulus is presented.

In the study, 22 eyes were re-treated with LASIK. Measurements of corneal sensitivity were taken prior to re-treatment and postoperatively on days 1, 30, and 90. Twenty eyes were measured with the NCCA with a mean measurement of corneal sensitivity at 0.55 millibars, referred to as baseline measurement. Measurements were taken on 4 locations and no statistical difference was found between these.

The 22 re-treated eyes were followed for 90 days. No great threshold values were found pre- and postoperatively. The possible explanation is that the A-delta fibers are arranged parallel to the anterior corneal surface at the basal cell layer and responds to mechanical pressure. The C-fibers reach up to within one cell of the epithelial surface and since the NCCA sends out a thermal element, it responded to the temperature change.

The NCCA's ability to measure functional recovery was able to determine successfully a healthy cornea, with no previous disease. In tests, previous contact lens-wearing eyes have shown to reduce corneal sensitivity. Post-LASIK patients also have a reduced corneal sensitivity, with a similar pattern as the contact lens-wearing patient. Re-treatment corneas do not loose as much corneal sensitivity as suspected.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.